Edesa Biotech is trading at $4.91, up +10.22%, as Velan Capital’s 9.99% stake disclosure boosts sentiment after selling pressure tied to the $25 million public offering.
- Velan purchased shares in the offering and disclosed warrant exposure; shares and accompanying warrants were priced at $5.50 per unit.
- Biotech gained 2.06%, while major indexes were mixed on August 26, 2026.
- Hero News ID: 6a8efa1e5d3b0ee9f03e19f4